Latest

glioblastoma

Brain Cancer Featured Neurology Neuroscience

·May 29, 2026·9 min read

Scramblase CLPTM1L May Drive Glioblastoma

A new study identifies an endoplasmic reticulum-localized lipid scramblase called CLPTM1L as the primary master regulator behind lipid raft formation in glioblastoma.

This shows the mesh used in this glioblastoma study.

Brain Cancer Featured Neurology Neuroscience

·May 28, 2026·10 min read

Localized Synergistic Nanofibers Could Eliminate Glioblastoma

A new study details a localized "NanoMesh" implant that delivers three synergistic drugs directly to the site of glioblastoma tumors.

Brain Cancer Featured Neurology Neuroscience

·May 12, 2026·13 min read

Personalized DNA Vaccine Doubles Glioblastoma Survival Rates

A "first of its kind" personalized DNA vaccine is doubling survival rates for patients with aggressive glioblastoma. By targeting 40 unique tumor proteins, twice as many as previous therapies, the GNOS-PV01 vaccine transforms "cold" tumors into "hot" targets for the immune system. With one patient remaining cancer-free five years late.

This shows a brain with cancer cells being blasted away by a laser.

Brain Cancer Featured Neurology Neuroscience

·February 26, 2026·8 min read

Laser Heat Unlocks Immunotherapy for Brain Cancer

Scientists use laser heat to "unseal" the blood-brain barrier, allowing immunotherapy to achieve record-breaking survival rates for brain cancer.

Brain Cancer Featured Genetics Neurology Neuroscience

·February 14, 2026·9 min read

Brain Tumor Pressure Triggers Neuron Death Pathways

It's not just the cancer that kills, it's the pressure. Scientists have discovered that physical force on the brain triggers a genetic "suicide" switch in healthy neurons.

Brain Cancer Featured Neurology Neuroscience

·October 3, 2025·7 min read

Glioblastoma Found to Erode Skull and Hijack Immune System

Glioblastoma, the most lethal brain cancer, doesn’t just damage the brain—it erodes the skull and disrupts the immune system by reshaping marrow inside the skull. Researchers discovered that tumors increase skull-to-brain channels, allowing waves of inflammatory immune cells to flow to the cancer site, fueling its growth.

Brain Cancer Featured Neurology Neuroscience

·September 18, 2025·6 min read

When Brain Cancer Cells Stick Together, They’re Less Dangerous

A groundbreaking study has revealed that glioblastoma cells behave differently depending on whether they cluster or disperse. Cells that remain in clusters are less aggressive, while dispersed cells are more plastic, meaning they can adapt and resist treatments more easily.

Brain Cancer Featured Genetics Neurology Neuroscience

·September 8, 2025·6 min read

Hidden DNA Loops Linked to Early Spread of Brain Cancer

Scientists have discovered that rogue DNA rings, called extrachromosomal DNA (ecDNA), appear early in glioblastoma and drive its rapid growth and resistance to therapy. By combining patient data, imaging, and computational modeling, researchers found that ecDNA often carries the EGFR cancer gene and its aggressive variants.

Brain Cancer Featured Neuroscience

·September 4, 2025·8 min read

Dietary Intervention Could Slow Deadly Brain Cancer Growth

A new study reveals that glioblastoma, the most aggressive brain cancer, thrives by using sugar in unique ways that differ from healthy brain cells. While normal brain tissue channels sugar into energy and neurotransmitters, glioblastoma cells divert it into producing DNA and RNA, fueling relentless tumor growth.

Brain Cancer Featured Neurology Neuroscience

·September 2, 2025·5 min read

Freezing Brain Molecules Could Halt Deadly Cancer Spread

Scientists have identified a new way to stop glioblastoma — the deadliest form of brain cancer — from spreading by altering its environment rather than targeting the tumor directly. The team showed that cancer cells depend on flexible hyaluronic acid molecules to invade surrounding brain tissue, but when these molecules were "frozen," cells became immobile and dormant.

Brain Cancer Featured Genetics Neurology Neuroscience

·May 30, 2025·6 min read

Lab-Designed Peptide Targets Glioblastoma Stem Cells

A newly developed lab-designed molecule, JM2, may offer a promising therapy to combat glioblastoma recurrence by targeting the tumor’s most resilient cells. Researchers discovered that glioblastoma stem cells rely on the protein connexin 43’s interaction with microtubules—an interaction disrupted by JM2.

Brain Cancer Featured Neurology Neuroscience

·May 15, 2025·4 min read

Gabapentin Linked to Longer Survival in Glioblastoma Brain Cancer

A new study suggests that gabapentin, a widely used anti-seizure medication, may improve survival in patients with glioblastoma (GBM), the deadliest form of brain cancer. Researchers found that GBM patients taking gabapentin lived several months longer than those who did not, across two independent hospital datasets.